Both in Pharmaceuticals
Teva Pharmaceutical Industries Limited vs Alnylam Pharmaceuticals
Over the past year TEVA returned +107.6% and ALNY returned −43.2%; their daily moves had a correlation of 0.19.
TEVA +107.6% ALNY −43.2%Growth of $1, one year, split-adjusted
| Metric | TEVA | ALNY |
|---|---|---|
| Price | $39.81 | $254.07 |
| Market cap | $46.43B | $34.00B |
| Today | +2.39% | −0.51% |
| 1 month | +9.2% | +7.2% |
| 6 months | +40.4% | −19.6% |
| Year to date | +27.6% | −36.1% |
| 1 year | +117.1% | −43.1% |
| Revenue growth (YoY) | −0.8% | +66.9% |
| Gross margin | 52.0% | 76.9% |
| Net margin | −13.9% | 12.7% |
| P/E (TTM) | 65.7× | 42.1× |
| Price / sales | 2.7× | 7.1× |
| Net cash | -$12.94B | $2.30B |
| Dividend yield | — | — |
| Volatility (60d) | 35.4% | 81.5% |
| Short % of float | 2.7% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).